The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 13, 2018

Filed:

Aug. 28, 2015
Applicant:

Tanaka Kikinzoku Kogyo K.k., Chiyoda-ku, Tokyo, JP;

Inventors:

Yasushi Masahiro, Tokyo, JP;

Toshiyuki Shigetomi, Tsukuba, JP;

Junichi Taniuchi, Tsukuba, JP;

Ryosuke Harada, Tsukuba, JP;

Assignee:
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07C 45/77 (2006.01); C07F 15/00 (2006.01); C07C 49/92 (2006.01); C09K 11/06 (2006.01); C23C 16/18 (2006.01); H01L 51/00 (2006.01); H01L 51/50 (2006.01);
U.S. Cl.
CPC ...
C07F 15/004 (2013.01); C07C 45/77 (2013.01); C07C 49/92 (2013.01); C09K 11/06 (2013.01); C23C 16/18 (2013.01); H01L 51/0085 (2013.01); C07F 15/00 (2013.01); C09K 2211/185 (2013.01); H01L 51/0002 (2013.01); H01L 51/5016 (2013.01);
Abstract

A method for manufacturing tris(β-diketonato)iridium by reacting β-diketone with an iridium compound, in which an activation treatment including (a) an alkali treatment and (b) an acid treatment described below is applied to the iridium compound to activate the iridium compound, and to subsequently react the β-diketone, (a) an alkali treatment: a treatment of adding alkali to a solution of the iridium compound to raise pH of the solution to a more alkaline side than that before the alkali addition and to not less than 10, and (b) an acid treatment: a treatment of adding acid to the solution subjected to the alkali treatment to lower pH of the solution to a more acidic side than that before the acid addition and to make the pH difference between solutions before and after the acid addition be not less than 0.1 and not more than 10. The present invention allows manufacture of tris(β-diketonato)iridium utilizing a wide variety of β-diketones.


Find Patent Forward Citations

Loading…